Seller comparison · US self-pay prices

Eden vs Fridays: GLP-1 Prices Compared

Eden and Fridays both sell compounded tirzepatide injection. Compounded tirzepatide injection: not ranked against each other, because neither price states the supply period it buys: Eden advertises $129/mo, Fridays $259/mo. The lower advertised figure is Eden's. Only Fridays sells compounded semaglutide injection here. Both sell only compounded GLP-1s here. Compounded GLP-1s are not FDA-approved. Prices checked Oct 17, 2026 and Oct 20, 2026.

Compare all 3 offers Eden prices Fridays prices

Every cash quote was checked on or after Oct 15, 2026. Each quote shows its own check date. A quoted price is not a recommendation of a seller, a product or a dose. How we source prices

Same product

What Eden and Fridays charge for the same medication

Entry prices first, then the published top-dose price where either seller states one. Each price links the seller's own page.

Compounded tirzepatide injection

Entry price: not ranked against each other, because neither price states the supply period it buys: Eden advertises $129/mo, Fridays $259/mo. The lower advertised figure is Eden's.

EEden

Advertised entry price

$129/mo

Supply period unverified; excluded from cost ranking.

Checked Oct 20, 2026

Compounded tirzepatide via Eden

Eden · Sourced provider quote

one price at every dose; no membership fee; no introductory rate

Price conditions

one price at every dose; no membership fee; no introductory rate

One flat monthly price at every dose, including doctor-guided care and free expedited shipping. No annual or long-term plan required. Compounded; not FDA-approved.

View offer

FFridays

Advertised entry price

$259/mo

Supply period unverified; excluded from cost ranking.

Checked Oct 17, 2026

Compounded tirzepatide via Fridays

Fridays · Sourced provider quote

1-month subscription that renews automatically; $696 for 3 months ($232/mo), $1,350 for 6 ($225/mo), $2,376 for 12 ($198/mo); consultation, care, medication, supplies and shipping included

Price conditions

1-month subscription that renews automatically; $696 for 3 months ($232/mo), $1,350 for 6 ($225/mo), $2,376 for 12 ($198/mo); consultation, care, medication, supplies and shipping included

Weekly injection. Its homepage shows the same plan prices with promo codes; a one-time 1-month supply is $389. Fridays also lists brand Ozempic at $1,498 and Zepbound at $1,828 a month. Compounded; not FDA-approved.

View offer

Sold by one of them

What only one of them sells

EEden

Everything Eden sells here is also sold by the other seller (above).

FFridays

Compounded semaglutide injection
Advertised entry price
$149/mo
Supply period unverified; excluded from cost ranking.
Checked Oct 17, 2026
Compounded semaglutide via Fridays
Fridays · Sourced provider quote
1-month subscription that renews automatically; $387 for 3 months ($129/mo), $654 for 6 ($109/mo), $1,188 for 12 ($99/mo); consultation, care, medication, supplies and shipping included
Price conditions
1-month subscription that renews automatically; $387 for 3 months ($129/mo), $654 for 6 ($109/mo), $1,188 for 12 ($99/mo); consultation, care, medication, supplies and shipping included
Weekly injection. Its homepage shows the same plan prices with promo codes; a one-time 1-month supply is $279. Its terms say medication is billed separately, while the subscription pages include it. Cancel at least 72 hours before the next billing date. Not available in every state. Compounded; not FDA-approved.
View offer

Compounded GLP-1s are not FDA-approved. Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality before they are marketed. FDA: concerns with unapproved GLP-1 drugs used for weight loss

Every sourced offer

All Eden and Fridays offers

Both sellers' quotes in one table, lowest 30-day cost first where the seller states its supply.

Search with AIA brand, a budget, or what you need

Try

3 offers · US self-pay

Compounded semaglutide via Fridays
Semaglutide · Compounded
Compounded · Not FDA-approved
F
Fridays
Advertised price$149/mo
Supply period unverified; excluded from cost ranking.
Checked Oct 17, 2026
Maintenance price
No separate dose price verified
View offer
Price conditions & source
Advertised price: 1-month subscription that renews automatically; $387 for 3 months ($129/mo), $654 for 6 ($109/mo), $1,188 for 12 ($99/mo); consultation, care, medication, supplies and shipping included
Weekly injection. Its homepage shows the same plan prices with promo codes; a one-time 1-month supply is $279. Its terms say medication is billed separately, while the subscription pages include it. Cancel at least 72 hours before the next billing date. Not available in every state. Compounded; not FDA-approved.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source
Compounded tirzepatide via Eden
Tirzepatide · Compounded
Compounded · Not FDA-approved
E
Eden
Advertised price$129/mo
Supply period unverified; excluded from cost ranking.
Checked Oct 20, 2026
Maintenance price
No separate dose price verified
View offer
Price conditions & source
Advertised price: one price at every dose; no membership fee; no introductory rate
One flat monthly price at every dose, including doctor-guided care and free expedited shipping. No annual or long-term plan required. Compounded; not FDA-approved.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source
Compounded tirzepatide via Fridays
Tirzepatide · Compounded
Compounded · Not FDA-approved
F
Fridays
Advertised price$259/mo
Supply period unverified; excluded from cost ranking.
Checked Oct 17, 2026
Maintenance price
No separate dose price verified
View offer
Price conditions & source
Advertised price: 1-month subscription that renews automatically; $696 for 3 months ($232/mo), $1,350 for 6 ($225/mo), $2,376 for 12 ($198/mo); consultation, care, medication, supplies and shipping included
Weekly injection. Its homepage shows the same plan prices with promo codes; a one-time 1-month supply is $389. Fridays also lists brand Ozempic at $1,498 and Zepbound at $1,828 a month. Compounded; not FDA-approved.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source

Read prices in context. Compare the same product, dose, and payment terms. A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes with documented supply periods, converted to 30 days. Other prices are unranked references. Dose changes, introductory terms and added fees affect what you pay.

Missing prices are not estimated. A listed maintenance dose is not a dosing recommendation.

The FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved, ending the exemption that let pharmacies mass-produce compounded copies, and the 503A/503B enforcement-discretion grace periods ended in 2025. The FDA is now actively enforcing (warning letters and takedowns, including a September 2026 warning letter to Empower Pharmacy, a large compounder, over products it called essentially copies of approved semaglutide and tirzepatide), and in 2026 proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list (the public comment period, extended 30 days, closed July 30, 2026; a final decision is pending). Liraglutide is different: it is still on the FDA drug shortage list (brand Victoza and Saxenda in limited supply, generics available, as of September 2026). Compounded GLP-1s are not FDA-approved and are now generally limited to narrow, patient-specific 503A prescriptions, so broad low-cost availability has largely wound down. They also carry safety risks the branded products do not: FDA adverse-event reports, at least one sterility recall (ProRx, October 2025), and counterfeit product found in the US supply chain, so a low price is not a low-risk signal. Prices and availability below may lag these changes; confirm current terms with the provider.

Questions

Eden vs Fridays: common questions

Is Eden or Fridays cheaper for GLP-1 medication?

Compounded tirzepatide injection: not ranked against each other, because neither price states the supply period it buys: Eden advertises $129/mo, Fridays $259/mo. The lower advertised figure is Eden's. Only Fridays: Compounded semaglutide injection $149/mo. Prices are the sellers' own advertised self-pay prices, with the conditions listed beside each.

Do Eden and Fridays sell FDA-approved GLP-1s or compounded versions?

Both sell only compounded GLP-1s here. Compounded GLP-1s are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality.

What do Eden and Fridays prices include?

Eden, compounded tirzepatide injection: $129/mo, one price at every dose; no membership fee; no introductory rate. Fridays, compounded tirzepatide injection: $259/mo, 1-month subscription that renews automatically; $696 for 3 months ($232/mo), $1,350 for 6 ($225/mo), $2,376 for 12 ($198/mo); consultation, care, medication, supplies and shipping included. Fridays, compounded semaglutide injection: $149/mo, 1-month subscription that renews automatically; $387 for 3 months ($129/mo), $654 for 6 ($109/mo), $1,188 for 12 ($99/mo); consultation, care, medication, supplies and shipping included.

When were Eden and Fridays prices last checked?

Prices checked Oct 17, 2026 and Oct 20, 2026. Each quote links the seller's own page it was read from. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.